C12N2710/16511 - CPC Classification Index

ClassID:

109864 ⎘

C12N2710/16511 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae Roseolovirus, e.g. human herpesvirus 6, 7

Sub-classes:

C12N2710/16521 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 1
C12N2710/16522 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 21
C12N2710/16523 » Virus like particles [VLP] 0
C12N2710/16531 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2710/16532 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 5
C12N2710/16533 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 1
C12N2710/16534 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral 1
C12N2710/16541 » Use of virus, viral particle or viral elements as a vector 2
C12N2710/16551 » Methods of production or purification of viral material 0
C12N2710/16561 » Methods of inactivation or attenuation 0
C12N2710/16571 » Demonstrated in vivo effect 4
C12N2710/16588 » For redistribution 0

Recent Application in this class:

20260116934

Compositions and Methods for Delivering CFTR Polypeptides

20210317174

COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES

20210087245

COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES

20200254060

Compositions and methods for delivering CFTR polypeptides

20190117766

Vaccine against beta-herpesvirus infection and use thereof

20130202638

Vaccine against beta-herpesvirus infection and use thereof

20060147939

Compositions and methods for detecting human herpesviruses

20060130161

Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes